28 Nov The future of digital therapies at Frontiers Health
The future of digital therapies at Frontiers Health
Xavier Palomer, CEO of Psious, led the panel“How VR is disrupting Therapy: a practical approach to DTx” at Frontiers Health, the digital health summit.
From November 13 to 15 Berlin hosted more than 600 experts in digital health at Frontiers Health, a global event that focuses on new digital therapies, innovative technologies that bring new practices in health, medical transformation and development of digital health.
During the three days more than 100 speakers presented the different challenges of the future of digital health, Xavier Palomer, CEO of Psious, had the opportunity to lead the session “How VR is disrupting Therapy: a practical approach to DTx” that emphasized the new opportunities and challenges that virtual reality offers as a tool in digital therapies.
The session was organized in two parts, a first where the protagonists in offering new solutions with virtual reality for digital therapies presented each of their tools. First, Diane Joordi, Chief Scientific Officer of Oncomfort (a company that provides patients with a self-control tool for stress and anxiety), then Barnaby Perks, co-founder and CEO of Oxford VR (focused on solutions for depression and anxiety disorders) and lastly, Marek Ostroswki, founder of Prosoma (specialized solution in cancer patients).
At the end of the presentations, Christopher Eccleston, Director of the Center for Pain Research The University of Bath and Sammeli Liikkanen, Chief Digital Officer of onion Corporation joined the session. In this second part, the discussion focused on the mode of action of virtual reality, the potential of digital therapy and the greater ease of access to it, which finally, all participants, concluded that it would benefit the control of Patient symptoms and an improvement in the quality of life.
Frontiers Health, concludes by being an event that puts its attention on the future of health and its future technological applications that will give greater efficacy in clinical results. In fact, in the first months of 2019, 1.5 billion euros were invested in telemedicine and 1 billion in health, among others.